anethole has been researched along with rotenone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bakhtiari, N; Farbood, Y; Ghafouri, S; Hajipour, S; Khoshnam, SE; Mansouri, E; Sarkaki, A; Vastegani, SM | 1 |
Bakhtiari, N; Farbood, Y; Ghafouri, S; Khoshnam, SE; Mansouri, E; Moradi Vastegani, S; Sarkaki, A | 1 |
Bakhtiari, N; Farbood, Y; Ghafouri, S; Khoshnam, SE; Moradi Vastegani, S; Sarkaki, A | 1 |
3 other study(ies) available for anethole and rotenone
Article | Year |
---|---|
Neuroprotective effect of anethole against rotenone induced non-motor deficits and oxidative stress in rat model of Parkinson's disease.
Topics: Animals; Antioxidants; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Male; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Rats; Rats, Wistar; Rotenone; Superoxide Dismutase | 2023 |
Anti-inflammatory, anti-apoptotic, and neuroprotective potentials of anethole in Parkinson's disease-like motor and non-motor symptoms induced by rotenone in rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cytokines; Disease Models, Animal; Neuroprotective Agents; Parkinson Disease; Rats; Rotenone | 2023 |
Anethole attenuates motor dysfunctions, striatal neuronal activity deficiency and blood brain barrier permeability by decreasing striatal α-synuclein and oxidative stress in rotenone-induced Parkinson's disease of male rats.
Topics: alpha-Synuclein; Animals; Antioxidants; Blood-Brain Barrier; Disease Models, Animal; Monoamine Oxidase; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Rats; Rats, Wistar; Rotenone; Superoxide Dismutase; Weight Loss | 2023 |